Thoracic Cancer clinical trials at UCSF

1 research study open to eligible people

Thoracic cancer is cancer in the chest, often in the lungs. UCSF is studying how cancer-related fatigue happens in patients treated with chemo and radiation. UCSF is analyzing blood and molecular markers in an observational study.

Showing trials for

  • Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

    open to eligible people ages 18 years and up

    Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.

    San Francisco, California

Our lead scientists for Thoracic Cancer research studies include .

Last updated: